SCSC vs VRTX · P/E 15, rev $3.04B vs P/E 30, rev $12.00B
ScanSource Inc (SCSC) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
ScanSource Inc (SCSC) is a electronics & computer distribution company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SCSC revenue for 2025-06-30 was $3.04B. Net income was $71.5M. Revenue was down 6.7% from 2024-06-30 to 2025-06-30. SCSC currently screens at market cap $988.6M and trailing P/E 14.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SCSC currently screens at market cap $988.6M and trailing P/E 14.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SCSC and VRTX stock pages for the full models.
Not investment advice.